Amount Raised
$80 Million
Round Type
Series C
South San FranciscoBiotechnologyHealth CareInvestors
Description
Frontier Medicines Corporation, a Boston, MA- and San Francisco, CA-based precision medicine company developing therapies against otherwise undruggable disease-causing targets, received $80M in Series C funding.
Quick answer
Frontier Medicines Corp raised $80 Million in a Series C round, dated February 25, 2024. Investors: RA Capital Management, Mpm Capital, DCVC Bio, Galapagos Nv (Euronext & Nasdaq: Glpg), Droia Ventures and Deerfield Management Company. Frontier Medicines Corp is based in South San Francisco, California, United States.
- How much did Frontier Medicines Corp raise?
- Frontier Medicines Corp raised $80 Million in a Series C round on February 25, 2024.
- Who invested in Frontier Medicines Corp?
- RA Capital Management, Mpm Capital, DCVC Bio, Galapagos Nv (Euronext & Nasdaq: Glpg), Droia Ventures and Deerfield Management Company are named as investors in this round.
- What does Frontier Medicines Corp do?
- Frontier Medicines Corporation is a precision medicine company developing therapies against otherwise undruggable disease-causing targets.
- Where is Frontier Medicines Corp based and how big is it?
- Frontier Medicines Corp is based in South San Francisco, California, United States. Fundz records about 80 employees.
- Who are the decision-makers at Frontier Medicines Corp?
- Fundz holds 1 contact at Frontier Medicines Corp, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Frontier Medicines Corp that raised within 45 days of this round, from Fundz verified event records.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
- Elucent Medical raised $43M (Series C) on April 10, 2024.
- Neuronostics raised $2.7M (Seed) on April 8, 2024.
- Neurovalens raised $2.7M (Seed) on April 8, 2024.
- D3 Bio raised $62M (Series A) on April 8, 2024.
Who to call at Frontier Medicines Corp, and when
A new round usually means Frontier Medicines Corp is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Frontier Medicines Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Frontier Medicines Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Frontier Medicines Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Frontier Medicines Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frontier Medicines Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.